FCMC
PFE icon

Founders Capital Management (Connecticut)’s Pfizer PFE Stock Holding History

Founders Capital Management (Connecticut)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,240
Closed -$211K – 59
2019
Q1 		$211K Buy
+5,240
New +$210K 0.08% 56

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Founders Capital Management (Connecticut)'s PFE Position: Q2 2019 in Review

Founders Capital Management (Connecticut) sold out of Pfizer (PFE) in Q2 2019, closing a stake of 5,240 shares — an estimated $211K sold.

Founders Capital Management (Connecticut) first reported a position in PFE in Q1 2019 and held it in 1 quarter. The position peaked at $211K in Q1 2019. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

  • Founders Capital Management (Connecticut) reported no remaining Pfizer position as of Q2 2019 after selling out during the quarter.
  • Founders Capital Management (Connecticut) sold 5,240 Pfizer shares in Q2 2019, an estimated $211K.
  • Founders Capital Management (Connecticut) first reported a position in Pfizer in Q1 2019 and held it in 1 quarter.
  • Founders Capital Management (Connecticut)'s Pfizer position peaked at $211K in Q1 2019.
  • 2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Founders Capital Management (Connecticut)'s 13F filing for Q2 2019, filed 11 Jul 2019.